- Home
- News
-
Ellison Institute Expands Planned Oxford Campus
Ellison Institute Expands Planned Oxford Campus
17 October 2023
Additional property acquisition, part of The Oxford Science Park, is adjacent to the recently purchased Littlemore House
OXFORD, U.K. – The Lawrence J. Ellison Institute for Transformative Medicine is adding to its planned Oxford scientific campus, which will be a permanent home to research laboratories, a patient clinic, educational facilities, and collaborative spaces in support of the Ellison Institute’s research and healthcare strategy.
The Ellison Institute acquired the 3.5 acre “Plot 18” from Magdalen College, part of Oxford University, through a 150-year land lease arrangement. The newly purchased property will connect with the adjacent 5.9-acre Littlemore House site that the Ellison Institute acquired late last year.
“We look forward to continuing the development of our Oxford presence and partnerships,” said Dr. David Agus, founding director and CEO of the Ellison Institute. “These acquisitions give us greater capacity to undertake critical biomedical research as well as the educational initiatives of the Institute in collaboration with Oxford University.”
The Ellison Institute is an interdisciplinary, patient-centered research center that provides cutting-edge cancer care and wellness services, undertaking research initiatives that span the scientific spectrum to change how cancer and other diseases are treated.
The Oxford Science Park was created by Magdalen College Oxford in 1991 as part of its mission to support discovery, innovation, and entrepreneurship. It is home to world-class research, engineering, technology and clinical expertise, and aims to be environmentally, economically, and socially sustainable.
Rory Maw, CEO of The Oxford Science Park, said, “We’re delighted to welcome the Ellison Institute to the Park and look forward to working with the team to help deliver their vision for the new Oxford campus. This commitment will reinforce the ground-breaking research and development already taking place on the Park, delivering benefits and opportunities for our occupiers and the wider Oxford innovation ecosystem.”
Dinah Rose QC, President of Magdalen College, said, “Following closely on from our strategic partnership with GIC, the Singapore sovereign wealth fund, this is an exciting next step in the evolution of the Park. We look forward to developing a close, long-term relationship with the Ellison Institute and to enhancing further Oxford’s enormous contribution to addressing global health challenges.”
The Global Health Security Consortium (GHSC), a joint initiative of the Tony Blair Institute for Global Change, the Ellison Institute, and scientists at the University of Oxford, will be one of the many Ellison Institute projects based out of the new campus. GHSC provides insight, analysis, and support for world leaders to help them deal with Covid-19 and future health security challenges.
The new campus will also enable the Ellison Institute to build collaborations with local companies such as Oxford Nanopore, also located within The Oxford Science Park. This collaboration will allow the Ellison Institute to link Oxford Nanopore’s gene sequencing technology to other life science technologies in the Institute’s network.
About the Ellison Institute
The Lawrence J. Ellison Institute for Transformative Medicine brings together interdisciplinary experts in scientific research, technology, cancer care, engineering, infectious disease, and more to push the boundaries of medicine and propel scientific advancement. We are fueled by hope. We center patients in everything we do. We want to change not only how the world prevents, detects, and treats cancer but how it delivers health and medicine. Together with our partners, we’re developing better cancer detection techniques, a deeper understanding of disease and well-being, and novel models for research into the human body. Our unique approach and physical spaces serve as catalysts for innovation, inspiration, and reimagining the status quo in medical research, cancer treatment, the patient experience, and global health. Learn more about the Institute and our work at eitm.org.
Read other news articles